/
/
Sulfasalazine Delayed Release 1000 mg Tablets – Sulfiron DR 1000

Sulfasalazine Delayed Release 1000 mg Tablets – Sulfiron DR 1000

Sulfasalazine 1000mg
Packing – 10X15 Blister

Sulfasalazine Delayed Release 1000 mg Tablets – A Reliable Ally for Managing Inflammatory Conditions.

Sulfiron DR 1000 – Sulfasalazine Delayed Release 1000 mg Tablets

Sulfasalazine 1000mg – Sulfasalazine Delayed Release 1000 mg Tablets are designed to bypass the stomach and release the active components directly into the intestines for targeted action. Once metabolized into sulfapyridine and 5-aminosalicylic acid (5-ASA):
5-ASA acts locally in the intestinal lining to reduce inflammation, making it highly effective for ulcerative colitis and Crohn’s disease.
Sulfapyridine provides systemic immune-modulatory effects, slowing disease progression and alleviating symptoms of rheumatoid arthritis and ankylosing spondylitis.
This formulation minimizes irritation to the upper digestive tract, making it suitable for long-term use in chronic conditions.

Recommended by specialists:

✅Rheumatologists: For the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, and other inflammatory joint conditions as part of DMARD (Disease-Modifying Antirheumatic Drugs) therapy.
✅Gastroenterologists: For managing inflammatory bowel diseases, such as Ulcerative colitis and Crohn’s disease and used to reduce inflammation in the lining of the colon and manage flares.
✅General Physicians: For continued care in chronic inflammatory conditions, especially when specialist access is limited or for dose maintenance and monitoring.

Key benefits of Sulfasalazine Delayed Release 1000 mg Tablets – Sulfiron DR 1000:

✅Targeted Release Mechanism:
The delayed-release formulation ensures the drug reaches the lower gastrointestinal tract, maximizing its effectiveness in treating inflammatory bowel diseases.
✅Dual Benefits: Combines anti-inflammatory and immunosuppressive actions, addressing both gut inflammation and joint pain.
✅Optimized Tolerability: Reduces gastrointestinal side effects commonly associated with standard formulations, enhancing patient compliance.

Indications:

Ulcerative Colitis
Crohn’s Disease
Rheumatoid Arthritis
Ankylosing Spondylitis

Follow us on

Proin volutpat vitae libero at tincidunt. Maecenas sapien lectus, vehicula vel euismod sed, vulputate

10% off when you sign up

Proin volutpat vitae libero at tincidunt. Maecenas sapien lectus, vehicula vel euismod sed, vulputate